Hematologic Oncology Update

ASHRLD11 - A 72-year-old man with a prior history of CAD presents with confusion, high-grade fever and pancytopenia and is diagnosed with AML with 24 percent myeloblasts. Case discussion moderated by Neil Love, MD. Produced by Research To Practice.

ASHRLD11 - A 54-year-old woman with MM and normal cytogenetics receives lenalidomide, bortezomib and dexamethasone (RVD) on the SWOG-S0777 study followed by maintenance lenalidomide. Case discussion moderated by Neil Love, MD. Produced by Research To Practice.

ASHRLD11 - A 60-year-old man who has a history of a progressive neuroendocrine pancreatic tumor treated surgically, radiopharmaceutically and systemically receives a presumptive diagnosis of CMML-2. Case discussion moderated by Neil Love, MD. Produced by Research To Practice.

ASHRLD11 - A 48-year-old woman with APL and a 15;17 translocation receives idarubicin and ATRA followed by consolidation ATO, ATRA and methotrexate/6-MP. Case discussion moderated by Neil Love, MD. Produced by Research To Practice.

ASHRLD11 – Clinical Investigators Provide Their Perspectives on the Management of Multiple Myeloma, Myelodysplastic Syndromes and Acute Myeloid Leukemias. Featuring William I Bensinger, MD, Pierre Fenaux, MD, Morie A Gertz, MD, Farhad Ravandi, MD, B Douglas Smith, MD and Ravi Vij, MD. Moderated by Neil Love, MD. CME Information and Program PDF. Produced by Research To Practice.

ASHTB11 – National NHL Tumor Board. Clinical Investigators Provide Their Perspectives on Cases of NHL and CLL. Interview with Jonathan W Friedberg, MD, MMSc conducted by Neil Love, MD. Produced by Research To Practice.

ASHTB11 – National NHL Tumor Board. Clinical Investigators Provide Their Perspectives on Cases of NHL and CLL. Interview with Mitchell R Smith, MD, PhD conducted by Neil Love, MD. Produced by Research To Practice.

ASHTB11 - A 63-year-old man with a 10-cm lung mass and no other evidence of systemic disease is diagnosed with Stage I bulky FL and undergoes treatment with BR and consolidation radiation therapy. Case discussion moderated by Neil Love, MD. Produced by Research To Practice.

ASHTB11 - A 67-year-old man with rapidly recurrent FL after FMR induction and R maintenance receives R-CVP but then switches to BR and achieves complete remission. Case discussion moderated by Neil Love, MD. Produced by Research To Practice.

ASHTB11 - A 57-year-old woman with relapsed CLL and a 17p deletion experiences rapid disease progression after BR and receives fludarabine/alemtuzumab followed by allogeneic stem cell transplant. Case discussion moderated by Neil Love, MD. Produced by Research To Practice.